Posts Tagged ‘urinary bladder cancer biomarker panel’
Recent Patents on Biomarkers
Posted October 25, 2012
on:
Highlights of recent US patents (issued and applications) on protein biomarkers and molecular diagnostics.
(Click on titles to view the details)
1. Gene expression biomarker panel for the prognosis of urinary bladder cancer.
2. Detection of cancer using multiplex Liquid Tissue Arrays TM derived from formalin-fixed tissues.
3. Detection of cancers using transcription infidelity domains.
4. Prognostic biomarkers of pancreatic cancer.
5. Circulating miRNA biomarkers of prostate cancer.
6. Protein biomarker for the detection of endometrial cancer.
7. Diagnosing hematological cancers using circulating tyrosine kinases (cTK).
8. Serum CD200 for detecting chronic lymphocytic leukemia (CLL).
9. Dection of granulocytic anaplasmosis caused by the tick-borne pathogen Anaplasma phagocytophilum.
10. VEGF-D for the diagnosis of lymphangioleiomyomatosis (LAM).
11. Diagnosis of babesiosis caused by tick-borne parasite Babesia microti.
12. Prognostic biomarkers of chronic heart failure (CHF).
13. Methods of diagnosing IgA nephropathy.
14. Mass spectrometry with high reproducibility using MALDI-TOF MS plate with nanodot regions.
15. Polymorphic markers of determining susceptibility to Atrial fibrillation, Atrial flutter, and Stroke.
16. Gene expression biomarkers for the detection of thrombocytosis.
17. Micro RNAs for diagnosing chronic obstructive pulmonary disease (COPD).
18. Free pregnancy associated plasma protein A (PAPP-A) for the diagnosis of acute coronary syndrome.
19. Soluble fms-like tyrosine kinase-1 (sFLT-1) for the diagnosis of myocardial infarction.
20. Genetic test for screening risk in developing Charcot-Marie-Tooth Disease Type 2A.
21. Molecular diagnostic assays for the diagnosis of bacterial vaginosis.
Related blogs on biomarkers:
Strategies for Rational and Personalized Cancer Biomarker Discovery
Cancer Theranostics – Potential Applications of Cancer Biomarker Database
How to Identify Clinically Successful Biomarkers?
Metabolon vs. Stemina – Are Biomarkers Patents can be Considered as “True Inventions”?
Related tools:
Comprehensive cancer biomarker database with companion diagnostics pathway
Recent Comments